Followers | 43 |
Posts | 8463 |
Boards Moderated | 3 |
Alias Born | 11/23/2003 |
Monday, February 20, 2017 8:31:16 AM
....This PR News isn't that old but to look at each category is monumental into scientific research for the betterment of mankind..
****In 2014, PKTX filed for a series of new patents based on results generated by the University of Alberta trials. These are brand new applications protected by worldwide provisional patents.
The Company has completed a series of mechanism of action studies, showing how the molecule achieves its effect of inhibiting inflammation and protecting cells from premature death. This data will enable PKTX to more clearly identify the optimal therapeutic uses for disease.
..Stem cell research has demonstrated major benefits of using AAGP™ during the following stages:
1. Freeze/thaw recovery (cryopreservation)
2. Primary differentiation
3. Migration to progenitor status (precursor cells)
4. Transplantation
5. Engraftment
6. Protection against anti-rejection drugs
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM